Status:
UNKNOWN
Efficacy and Safety of Longan Syrup in Healthy Volunteers With Insomnia
Lead Sponsor:
Chulalongkorn University
Conditions:
Insomnia
Eligibility:
All Genders
35-65 years
Phase:
NA
Brief Summary
The objectives of this study were to evaluate efficacy and safety of longan syrup in healthy volunteers with insomnia. Subjects will take 15 ml of longan syrup once a day for 3 months. They will be in...
Eligibility Criteria
Inclusion
- Age 35-65 years
- Insomnia severity index (ISI) more than 7
- Thai- The Pittsburgh Sleep Quality Index (PSQI)) more than 5
- STOP - BANG less than 5
- No diabetes mellitus and thyroid dysfunction
- Fasting plasma glucose less than 126mg/dl
- Can communication (reading and writing)
- Be willing to be subjects in this study
Exclusion
- Know longan allergy or have history of adverse events from longan
- Take benzodiazepine, melatonin, valerian, and St Johns Wort in 1 month before this study starting
- Take medicines, herbs, or food supplements including thiazide diuretics, beta-blockers ,and estrogen that have an effect on blood sugar level in 1 month before this study starting
- Cannot control comorbidity diseases
- Irregular working hours
- Pregnancy or breast feeding
- Participated in other studies
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 10 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04300036
Start Date
March 1 2020
End Date
February 10 2021
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn Unviersity
Bangkok, Thailand, 10310